Pagharap sa Addiction

Mahahalagang Punto

• Ang epektibong addiction care ay gumagamit ng continuum mula early intervention tungo sa treatment at long-term recovery support.
• Pinagsasama ng medication-assisted treatment ang pharmacotherapy at behavioral care at pinapabuti ang retention at outcomes.
• Mahalaga sa medisina ang withdrawal stabilization ngunit hindi ito kumpletong treatment para sa substance use disorder.
• Ang collaborative at nonjudgmental na care ay nagpapababa ng relapse at overdose risk pagkatapos ng detox.
• Major risk point ang detox follow-through; maraming clients ang hindi kailanman nakakapasok sa continuing treatment nang walang active linkage support.
• Ang behavioral compulsive-use patterns (halimbawa sobrang screen/social-media/gaming exposure) ay maaaring magpalala ng sleep, concentration, anxiety, at depressive symptom burden sa emerging adults.

Patopisyolohiya

Ipinapakita ng addiction ang chronic neurobehavioral dysregulation na nakaaapekto sa reward, stress response, at executive control. Ang acute withdrawal ay nagde-destabilize ng maraming physiologic systems at maaaring maging life-threatening sa alcohol o benzodiazepine dependence.

Mataas ang panganib pagkatapos ng detox dahil bumababa ang tolerance. Kung bumalik ang tao sa dating doses, malaki ang pagtaas ng overdose risk, lalo na sa opioids.

Bumubuti ang treatment outcomes kapag pinamamahalaan ang SUD bilang chronic condition (katulad ng hypertension o diabetes) na may sustained evidence-based care, supportive monitoring, at coordinated social support sa halip na iisang maikling episode of care.

Klasipikasyon

• Early intervention stage: Screening, brief intervention, guided self-change.
• SBI/SBIRT stage: Structured screening kasama ang brief intervention at referral sa specialty treatment kapag naaangkop.
• Active treatment stage: Detox/stabilization, medication, psychotherapy, structured programming.
• Recovery support stage: Peer/community supports, relapse prevention, long-term follow-up.
• Stepped-intensity continuum: Inpatient withdrawal management, residential treatment, partial hospitalization/intensive outpatient, pagkatapos ay lower-intensity outpatient self-management support.
• Withdrawal-to-treatment gap: Maraming clients ang humihiwalay pagkatapos ng detoxification lamang; karaniwang inuulat na hanggang humigit-kumulang three-quarters ang hindi pumapasok sa continuing treatment nang walang active linkage.
• Chronic-care framing: Maaaring mangyari ang relapse at hindi ito katumbas ng treatment failure; inaasahan ang plan revisions at sustained supports.
• Recovery-definition framing: Mahalaga ang abstinence ngunit kabilang din sa recovery ang pinahusay na health, function, at self-directed living.
• ROSC framing: Gumagamit ang recovery-oriented systems of care ng long-term monitoring (halimbawa checkups/case monitoring), recovery housing, at recovery coaching upang bawasan ang relapse burden.
• Behavioral-use risk stage: Non-substance reward-loop behaviors na may variable-reward reinforcement at impaired self-limiting control.

Nursing Assessment

Pokus sa NCLEX

Tukuyin kung kailangan ng client ang emergency overdose care, acute withdrawal stabilization, o step-down recovery support.

• Suriin ang substance history, current symptoms, at agarang medical risk.
• Ipalagay na maaaring underreported ang use history at isama ang collateral cues mula sa current symptoms, family reports, at objective clinical findings.
• Suriin ang overdose signs ayon sa substance type (opioid, stimulant, alcohol, medication ingestion).
• Suriin ang withdrawal trajectory, severity, at complication risk (seizure, delirium, autonomic instability).
• Gumamit ng structured withdrawal tools ayon sa substance (halimbawa CIWA-Ar para sa alcohol at COWS para sa opioids) upang suportahan ang protocol-based dosing at reassessment.
• Suriin ang stage of readiness for change (precontemplation hanggang maintenance).
• Sa general-care settings (halimbawa primary care, obstetrics-gynecology, emergency, at medical-surgical units), panatilihing mataas ang suspicion para sa undiagnosed SUD at mag-screen nang maaga.
• Gumamit ng validated screening tools sa routine care workflows (halimbawa AUDIT para sa alcohol) at mag-escalate mula screening tungo sa brief intervention/referral batay sa risk severity.
• Direktang suriin ang treatment-access barriers (readiness, cost/insurance, stigma/job impact concerns, transportation, at treatment-program fit).
• Hayagang suriin ang readiness-for-change stage (precontemplation, contemplation, preparation, action, maintenance) at iangkop ang teaching intensity sa stage.
• Sa younger adults, suriin ang daily screen/gaming/social-media exposure pattern at timing kapag may insomnia, inattention, o mood decline.
• Suriin ang co-occurring mental-health conditions at epekto ng mga ito sa treatment engagement/retention.
• Suriin ang infectious-disease risk sa ongoing misuse contexts (halimbawa HIV, hepatitis B/C, tuberculosis exposure risk) at readiness para sa prevention counseling/testing.
• Suriin ang support network, housing, insurance access, at treatment continuity barriers.

Nursing Interventions

• Maghatid ng mabilis na overdose response: stimulation check, emergency activation, airway support/resuscitation, at opioid reversal na may repeat naloxone dosing bawat 2-3 minuto kapag kailangan.
• Gumamit nang maaga ng poison-control o bedside toxicology consultation para sa uncertain o mixed ingestions upang mapino ang antidote at monitoring plans.
• Sa pinaghihinalaang alcohol overdose, protektahan ang airway at gumamit ng side-lying o partially upright positioning para sa unresponsive clients upang mabawasan ang aspiration risk.
• Mag-ayos ng urgent transfer para sa monitored medical care kahit mukhang sapat ang early naloxone response.
• Gumamit ng validated withdrawal protocols at madalas na reassessment para sa symptom-guided treatment.
• Ilapat ang SBIRT sequence kapag naaangkop: mag-screen sa routine care, maghatid ng nonjudgmental brief intervention, pagkatapos ay kumpletuhin ang active referral kapag ang disorder severity o failed brief response ay nangangailangan ng specialty care.
• Gumamit ng brief quit-coaching structure kapag naaangkop: magtakda ng quit date, alisin ang triggers sa kapaligiran, magsanay ng urge-distraction techniques, repasuhin ang prior quit attempts, at bumuo ng support network.
• Magbigay ng edukasyon tungkol sa relapse risk pagkatapos ng detox at individualized safety planning.
• I-frame nang malinaw ang detoxification bilang stabilization step, pagkatapos ay tiyakin ang mabilis na paglipat sa ongoing treatment dahil karaniwan ang disengagement pagkatapos ng withdrawal management.
• Bumuo ng retention plans sa paligid ng chronic-care timelines; maraming clients ang nangangailangan ng hindi bababa sa humigit-kumulang 3 buwan ng active treatment, at ang severe SUD ay karaniwang nangangailangan ng humigit-kumulang 1 taon ng staged engagement sa iba’t ibang settings.
• Palakasin na maaari pa ring maging epektibo ang treatment kahit sa simula ay externally motivated (halimbawa family, work, o legal pressure), pagkatapos ay ilipat paunti-unti tungo sa internal motivation.
• Para sa compulsive screen-use patterns, magturo ng trial behavior plans (use diary, pre-sleep device cut-off, at structured replacement activities) at i-monitor ang symptom response.
• I-coordinate ang discharge sa inpatient, residential, community, IOP, at peer-support options.
• Iugnay ang clients sa recovery support services (mutual aid groups, recovery coaches, recovery housing, at community/education-based recovery programs) upang mapabuti ang long-term remission stability.
• Isama ang client at family peer-network options (halimbawa AA/NA, Nar-Anon/Al-Anon, NAMI pathways, at veteran-focused supports kapag naaangkop) na may face-to-face o virtual access plans.
• Magbigay ng crisis-escalation access teaching (U.S. 988) para sa acute mental-health o substance-related crisis moments.
• Gumamit ng harm-reduction interventions para sa clients na hindi pa handa sa abstinence (halimbawa overdose-prevention education, naloxone access, at safer-use infection-risk reduction services) habang pinananatiling bukas ang treatment pathways.
• I-coordinate ang infectious-disease screening at risk-reduction counseling sa loob ng SUD treatment plans.
• Gumamit ng culturally responsive, trauma-informed, at stigma-free communication sa lahat ng encounters.
• Gumamit ng person-first at non-stigmatizing language at iwasto ang myths na naglalarawan sa SUD bilang moral failure o kakulangan ng willpower.

Hindi Sapat ang Detox Lamang

Ang withdrawal management na walang follow-up treatment ay may mataas na relapse at overdose risk.

Pharmacology

Kabilang sa MAT medications ang buprenorphine-naloxone, methadone, at naltrexone para sa opioid-related disorders. Karaniwang ginagamit ang buprenorphine-naloxone para sa detoxification o maintenance; ang methadone para sa OUD ay Schedule II medication na ibinibigay sa pamamagitan ng SAMHSA-certified at state-approved opioid treatment programs. Hindi scheduled ang naltrexone at maaaring mapabuti ng extended-release injection formulations ang relapse-prevention adherence.

Kabilang sa AUD medications ang naltrexone, acamprosate, at disulfiram; nangangailangan din ang piling clients ng nutritional repletion tulad ng thiamine at magnesium.

Maaaring kabilang sa nicotine-use treatment ang nicotine-replacement therapies (patch, gum, lozenge, spray) o oral options gaya ng bupropion o varenicline kapag isinama sa behavioral treatment.

Gumagamit ang alcohol withdrawal ng benzodiazepines bilang first-line therapy para sa seizure at delirium tremens prevention at maaaring mangailangan ng thiamine/electrolyte correction; maaaring mangailangan ng ICU-level care ang severe cases. Maaaring gamitin ang dexmedetomidine bilang adjunct para sa sympathetic overactivity sa ICU settings ngunit hindi nito ginagamot ang withdrawal seizures. Mino-monitor ng mga nars ang blood pressure, sedation level, respiratory status, renal risk, at medication response.

Para sa opioid withdrawal, karaniwang gumagamit ang first-line treatment ng buprenorphine kapag objectively present ang withdrawal; maaaring gamitin ang methadone na may maingat na monitoring dahil nananatiling clinically significant ang overdose risk. Ang alpha-2 adrenergic agonists gaya ng clonidine o lofexidine ay maaaring magpababa ng autonomic withdrawal symptoms.

Karaniwang ginagamit ang symptom-targeted detox medication bundles (halimbawa headache, GI upset, diarrhea, rhinorrhea, anxiety, at blood-pressure elevation support), na may nursing reassessment pagkatapos ng bawat dose. Para sa clonidine-based support, masusing i-monitor ang blood pressure trend, sedation burden, at renal-risk context.

Maaaring maging life-threatening ang benzodiazepine withdrawal at maaaring kabilang dito ang agitation, hallucinations, psychosis, seizures, at autonomic instability. Karaniwang pinapalitan sa pamamahala ang long-acting benzodiazepine at gumagamit ng mabagal at individualized taper (madalas humigit-kumulang 10-25% dose reduction bawat 1-2 linggo) upang mabawasan ang severe withdrawal complications.

Nanatiling mahalaga ang nonpharmacologic treatment: motivational interviewing, behavioral therapies, contingency-management incentives, family/group counseling, 12-step programs, at recovery-support services na nag-aalis ng practical barriers sa sustained care.

Clinical Judgment Application

Clinical Scenario

Natapos ng isang client ang inpatient detox at nag-uulat ng malalakas na cravings, mababang confidence, at hindi tiyak na follow-up plans.

• Recognize Cues: Nabawasang tolerance, mataas na craving, at mahinang post-discharge supports.
• Analyze Cues: Mataas ang agarang relapse at overdose risk kung walang continuity planning.
• Prioritize Hypotheses: Prayoridad ang ligtas na transition na may treatment engagement.
• Generate Solutions: Mag-ayos ng MAT follow-up, counseling, peer support, at crisis contacts.
• Take Action: I-finalize ang coordinated discharge plan na may family/team education.
• Evaluate Outcomes: I-verify ang appointments, support activation, at pag-unawa ng client sa relapse response.

Mga Kaugnay na Konsepto

• mga substance-use disorder - Batayang neurobiology at clinical syndrome framework.
• alcohol use disorder - Pamamahala ng withdrawal at delirium risk sa practice.
• mga stimulant use disorder - Natatanging safety profile ng intoxication at mood crash.
• opioid use disorder - Overdose-reversal at MAT-centered treatment pathway.
• kolaborasyon at koordinasyon ng care - Interprofessional model para sa sustained recovery.